159316 创新药E
已收盘 07-17 15:00:00
资讯
新帖
简况
创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅
新浪基金 · 07-17 19:15
创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅
7月17日华东医药跌5.82%,创新药ETF银华基金重仓该股
证券之星 · 07-17 16:38
7月17日华东医药跌5.82%,创新药ETF银华基金重仓该股
ETF午评 | 双创指数双双跌逾4%,CPO、CRO遭重挫,科创创新药ETF、通信ETF跌逾8%
格隆汇 · 07-17 11:42
ETF午评 | 双创指数双双跌逾4%,CPO、CRO遭重挫,科创创新药ETF、通信ETF跌逾8%
【ETF动向】7月16日创新药ETF银华基金跌0.33%,份额增加2.09亿份
证券之星 · 07-17 08:03
【ETF动向】7月16日创新药ETF银华基金跌0.33%,份额增加2.09亿份
7月16日长春高新涨5.40%,创新药ETF银华基金重仓该股
证券之星 · 07-16 16:25
7月16日长春高新涨5.40%,创新药ETF银华基金重仓该股
ETF午评 | 科创50冲高回落跌3.67%,创新药板块逆势上扬,科创创新药ETF涨近8%
格隆汇 · 07-15
ETF午评 | 科创50冲高回落跌3.67%,创新药板块逆势上扬,科创创新药ETF涨近8%
三笔大额BD集中落地,港股通创新药ETF易方达(159316)标的指数涨超4%
证券之星 · 07-15
三笔大额BD集中落地,港股通创新药ETF易方达(159316)标的指数涨超4%
【ETF动向】7月14日创新药ETF银华基金涨3.54%,份额增加2.56亿份
证券之星 · 07-15
【ETF动向】7月14日创新药ETF银华基金涨3.54%,份额增加2.56亿份
【ETF动向】7月14日港股通创新药ETF汇添富基金涨0.28%,份额增加1.99亿份
证券之星 · 07-15
【ETF动向】7月14日港股通创新药ETF汇添富基金涨0.28%,份额增加1.99亿份
创新药板块有望进入业绩验证阶段,港股通创新药ETF易方达(159316)近10日累计“吸金”超12亿元
证券之星 · 07-14
创新药板块有望进入业绩验证阶段,港股通创新药ETF易方达(159316)近10日累计“吸金”超12亿元
【ETF动向】7月13日创新药ETF银华基金跌0.82%,份额增加2.3亿份
证券之星 · 07-14
【ETF动向】7月13日创新药ETF银华基金跌0.82%,份额增加2.3亿份
【ETF动向】7月13日港股通创新药ETF汇添富基金跌1.46%,份额增加3.57亿份
证券之星 · 07-14
【ETF动向】7月13日港股通创新药ETF汇添富基金跌1.46%,份额增加3.57亿份
【ETF动向】7月13日港股创新药ETF银华基金跌1.59%,份额增加2.45亿份
证券之星 · 07-14
【ETF动向】7月13日港股创新药ETF银华基金跌1.59%,份额增加2.45亿份
创新药板块再度走强,港股通创新药ETF易方达(159316)连续5日“吸金”合计超12亿元
证券之星 · 07-10
创新药板块再度走强,港股通创新药ETF易方达(159316)连续5日“吸金”合计超12亿元
7月10日长春高新涨5.48%,创新药ETF银华基金重仓该股
证券之星 · 07-10
7月10日长春高新涨5.48%,创新药ETF银华基金重仓该股
【ETF动向】7月8日港股通创新药ETF南方基金跌1.27%,份额增加1.15亿份
证券之星 · 07-09
【ETF动向】7月8日港股通创新药ETF南方基金跌1.27%,份额增加1.15亿份
创新药再添重磅BD交易,港股通创新药ETF易方达(159316)连续3日获净流入合计近12亿元
证券之星 · 07-08
创新药再添重磅BD交易,港股通创新药ETF易方达(159316)连续3日获净流入合计近12亿元
【ETF动向】7月7日创新药ETF银华基金跌4.48%,份额增加6660万份
证券之星 · 07-08
【ETF动向】7月7日创新药ETF银华基金跌4.48%,份额增加6660万份
【ETF动向】7月6日创新药ETF银华基金涨0.93%,份额减少1.79亿份
证券之星 · 07-07
【ETF动向】7月6日创新药ETF银华基金涨0.93%,份额减少1.79亿份
【ETF动向】7月6日创新药ETF富国基金涨1.8%,份额增加1.22亿份
证券之星 · 07-07
【ETF动向】7月6日创新药ETF富国基金涨1.8%,份额增加1.22亿份
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159316","market":"SZ","secType":"STK","nameCN":"创新药E","latestPrice":1.1,"timestamp":1784271834000,"preClose":1.167,"halted":0,"volume":1322421887,"delay":0,"changeRate":-0.0574,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.067,"latestTime":"07-17 15:00:00","open":1.173,"high":1.177,"low":1.09,"amount":1477000000,"amplitude":0.0746,"askPrice":1.1,"askSize":14272,"bidPrice":1.099,"bidSize":10392,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":5,"adr":0,"adjPreClose":1.167,"symbolType":"fund","openAndCloseTimeList":[[1784251800000,1784259000000],[1784264400000,1784271600000]],"highLimit":1.284,"lowLimit":1.05,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":0.046296,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/159316","defaultTab":"news","newsList":[{"id":"2652440087","title":"创新药遭“错杀”?AH十余股狂泻逾10%!港股通创新药ETF(520880)、场内唯一药ETF同创历史最大单日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2652440087","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652440087?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:15","pubTimestamp":1784286900,"startTime":"0","endTime":"0","summary":"7月17日,A股港股深度调整,沪指跌3%失守3800点,创指暴跌7.15%,恒指跌1.78%。普跌之际,近期显著回暖的创新药资产亦未能幸免。 港股通创新药波动剧烈,康方生物、荣昌生物等7股跌超10%,100%创新药研发标的——港股通创新药ETF华宝日内振幅达7.83%,收跌6.09%,创上市以来最大单日跌幅。 本周来看,港股通创新药ETF华宝场内累跌3.79%,成交43.65亿元续创历史次高,继续放量反映热度仍高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-17/doc-iniickaw4155351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","IBBQ","06978","BK1161","MEDX","BK4588","FDN","159992","BK4550","FLHK","159316","BK1574","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652405038","title":"7月17日华东医药跌5.82%,创新药ETF银华基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652405038","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652405038?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:38","pubTimestamp":1784277532,"startTime":"0","endTime":"0","summary":"证券之星消息,7月17日华东医药跌5.82%,收盘报30.1元,换手率2.13%,成交量37.3万手,成交额11.41亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共45家,其中持有数量最多的公募基金为银华基金的创新药ETF银华。创新药ETF银华目前规模为151.77亿元,最新净值0.908,较上一交易日下跌0.27%,近一年上涨6.89%。创新药ETF银华的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000963","LU1969619763.USD","BK0188","BK0196","159316","BK0132","LU2328871848.SGD","BK0209","BK0175","BK0183","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652471369","title":"ETF午评 | 双创指数双双跌逾4%,CPO、CRO遭重挫,科创创新药ETF、通信ETF跌逾8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652471369","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652471369?lang=zh_cn&edition=full","pubTime":"2026-07-17 11:42","pubTimestamp":1784259729,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159316","159695","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652647825","title":"【ETF动向】7月16日创新药ETF银华基金跌0.33%,份额增加2.09亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2652647825","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652647825?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:03","pubTimestamp":1784246625,"startTime":"0","endTime":"0","summary":"证券之星消息,7月16日,创新药ETF银华基金(159992)跌0.33%,成交额18.92亿元。当日份额增加了2.09亿份,最新份额为199.95亿份,近20个交易日份额增加6.61亿份。当日资金净流入1.41亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为181.55亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-7.35%,近一个月超额回报为0.06%,管理人为银华基金公司,基金经理为马君 王帅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700006612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651412042","title":"7月16日长春高新涨5.40%,创新药ETF银华基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651412042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651412042?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:25","pubTimestamp":1784190337,"startTime":"0","endTime":"0","summary":"证券之星消息,7月16日长春高新涨5.40%,收盘报75.94元,换手率4.54%,成交量18.13万手,成交额13.45亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共29家,其中持有数量最多的公募基金为银华基金的创新药ETF银华。创新药ETF银华的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600026178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0188","159316","BK0075","BK0028","000661","BK0057"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436504","title":"ETF午评 | 科创50冲高回落跌3.67%,创新药板块逆势上扬,科创创新药ETF涨近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436504","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651436504?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:41","pubTimestamp":1784086864,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159316","159982","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105435","title":"三笔大额BD集中落地,港股通创新药ETF易方达(159316)标的指数涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105435","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651105435?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:59","pubTimestamp":1784084356,"startTime":"0","endTime":"0","summary":"截至10:25,恒生港股通创新药指数上涨4.6%,成份股中,派格生物医药-B上涨17.9%,科伦博泰生物上涨11.0%。同花顺iFinD数据显示,截至昨日,港股通创新药ETF易方达近10日获资金净流入超12亿元。昨日,迪哲医药、翰森制药、信达生物三笔重磅出海BD集中落地,涵盖ADC、双抗及代谢疾病等前沿领域,单笔交易总金额均达数十亿美元级别。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026071500016754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["516080","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651487671","title":"【ETF动向】7月14日创新药ETF银华基金涨3.54%,份额增加2.56亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651487671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651487671?lang=zh_cn&edition=full","pubTime":"2026-07-15 08:04","pubTimestamp":1784073846,"startTime":"0","endTime":"0","summary":"证券之星消息,7月14日,创新药ETF银华基金(159992)涨3.54%,成交额15.3亿元。当日份额增加了2.56亿份,最新份额为205.46亿份,近20个交易日份额增加11.25亿份。当日资金净流入7.88亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为179.9亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-7.05%,近一个月超额回报为0.3%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500008757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651876664","title":"【ETF动向】7月14日港股通创新药ETF汇添富基金涨0.28%,份额增加1.99亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651876664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651876664?lang=zh_cn&edition=full","pubTime":"2026-07-15 08:02","pubTimestamp":1784073767,"startTime":"0","endTime":"0","summary":"证券之星消息,7月14日,港股通创新药ETF汇添富基金(159570)涨0.28%,成交额43.62亿元。当日份额增加了1.99亿份,最新份额为168.44亿份,近20个交易日份额增加8.7亿份。当日资金净流入2.67亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为238.44亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.44%,近一个月超额回报为-0.32%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500008442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651177846","title":"创新药板块有望进入业绩验证阶段,港股通创新药ETF易方达(159316)近10日累计“吸金”超12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177846","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651177846?lang=zh_cn&edition=full","pubTime":"2026-07-14 18:47","pubTimestamp":1784026077,"startTime":"0","endTime":"0","summary":"截至收盘,恒生港股通创新药指数上涨0.04%,中证港股通医药卫生综合指数上涨0.6%,中证创新药产业指数上涨3.3%,中证生物科技主题指数上涨2.5%,沪深300医药卫生指数上涨2.2%。同花顺iFinD数据显示,截至昨日,港股通创新药ETF易方达(159316,联接基金A/C:024328/024329)近10日获资金净流入超12亿元。市场分析认为,创新药板块中报窗口期来临,2026年一季度,多家创新药企已实现收入同比40%以上的高速增长,部分生物科技公司成功扭亏为盈,若头部创新药企的业绩兑现延续一季度的高增长趋势,市场对板块的关注点,或逐渐从“预期修复”转向“业绩验证”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026071400039500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","06978","516080","BK1161","BK1574","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651414059","title":"【ETF动向】7月13日创新药ETF银华基金跌0.82%,份额增加2.3亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651414059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651414059?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:04","pubTimestamp":1783987440,"startTime":"0","endTime":"0","summary":"证券之星消息,7月13日,创新药ETF银华基金(159992)跌0.82%,成交额10.49亿元。当日份额增加了2.3亿份,最新份额为202.9亿份,近20个交易日份额增加11.39亿份。当日资金净流入7646.82万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为172.02亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.81%,近一个月超额回报为0.32%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400007323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651403231","title":"【ETF动向】7月13日港股通创新药ETF汇添富基金跌1.46%,份额增加3.57亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651403231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651403231?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:02","pubTimestamp":1783987347,"startTime":"0","endTime":"0","summary":"证券之星消息,7月13日,港股通创新药ETF汇添富基金(159570)跌1.46%,成交额35.99亿元。当日份额增加了3.57亿份,最新份额为166.45亿份,近20个交易日份额增加6.74亿份。当日资金净流入4.81亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为235.77亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-4.64%,近一个月超额回报为-0.46%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400007009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651403161","title":"【ETF动向】7月13日港股创新药ETF银华基金跌1.59%,份额增加2.45亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2651403161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651403161?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:02","pubTimestamp":1783987346,"startTime":"0","endTime":"0","summary":"证券之星消息,7月13日,港股创新药ETF银华基金(159567)跌1.59%,成交额21.64亿元。当日份额增加了2.45亿份,最新份额为109.66亿份,近20个交易日份额增加3.57亿份。当日资金净流入1.6亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为75.1亿元。港股创新药ETF银华基金跟踪标的为国证港股通创新药指数,成立(2024-01-03)以来超额回报为-6.37%,近一个月超额回报为-0.3%,管理人为银华基金公司,基金经理为马君。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400007006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650184286","title":"创新药板块再度走强,港股通创新药ETF易方达(159316)连续5日“吸金”合计超12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650184286","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650184286?lang=zh_cn&edition=full","pubTime":"2026-07-10 18:44","pubTimestamp":1783680278,"startTime":"0","endTime":"0","summary":"7月10日,市场震荡回调,创新药板块逆势走强,截至收盘,恒生港股通创新药指数上涨3.3%,中证港股通医药卫生综合指数上涨2.8%,中证创新药产业指数上涨3.2%,中证生物科技主题指数上涨3.0%,沪深300医药卫生指数上涨1.6%。同花顺iFinD数据显示,截至昨日,港股通创新药ETF易方达已连续5日获资金加码,合计约12.3亿元。有观点认为,创新药全链条政策环境已进入近五年最优,创新药产业或迎来发展红利期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026071000036448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","516080","159316","06978","159992","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650183905","title":"7月10日长春高新涨5.48%,创新药ETF银华基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650183905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650183905?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:27","pubTimestamp":1783672079,"startTime":"0","endTime":"0","summary":"证券之星消息,7月10日长春高新涨5.48%,收盘报69.5元,换手率3.69%,成交量14.76万手,成交额10.16亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共29家,其中持有数量最多的公募基金为银华基金的创新药ETF银华。创新药ETF银华的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0075","159316","000661","BK0046","BK0057","BK0028","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650510914","title":"【ETF动向】7月8日港股通创新药ETF南方基金跌1.27%,份额增加1.15亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2650510914","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650510914?lang=zh_cn&edition=full","pubTime":"2026-07-09 08:01","pubTimestamp":1783555315,"startTime":"0","endTime":"0","summary":"证券之星消息,7月8日,港股通创新药ETF南方基金(159297)跌1.27%,成交额5.26亿元。当日份额增加了1.15亿份,最新份额为34.75亿份,近20个交易日份额增加6.16亿份。当日资金净流入5687.36万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为24.3亿元。港股通创新药ETF南方基金跟踪标的为国证港股通创新药指数,成立(2025-09-12)以来超额回报为-6.7%,近一个月超额回报为-0.37%,管理人为南方基金公司,基金经理为张其思 叶震南。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900005673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649596704","title":"创新药再添重磅BD交易,港股通创新药ETF易方达(159316)连续3日获净流入合计近12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649596704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649596704?lang=zh_cn&edition=full","pubTime":"2026-07-08 18:23","pubTimestamp":1783506232,"startTime":"0","endTime":"0","summary":"截至收盘,恒生港股通创新药指数下跌1.0%,中证港股通医药卫生综合指数下跌1.0%,中证创新药产业指数下跌2.4%,中证生物科技主题指数下跌1.7%,沪深300医药卫生指数下跌1.5%。同花顺iFinD数据显示,截至昨日,港股通创新药ETF易方达已连续3日获资金净流入,合计近12亿元。这是继年初石药×阿斯利康185亿美元、信达×礼来88.5亿美元之后,又一起由全球头部药企接盘的BD交易,反映出中国创新药管线资产在全球范围内的认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026070800035668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316","516080","159992","06978","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649955168","title":"【ETF动向】7月7日创新药ETF银华基金跌4.48%,份额增加6660万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649955168","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649955168?lang=zh_cn&edition=full","pubTime":"2026-07-08 08:04","pubTimestamp":1783469045,"startTime":"0","endTime":"0","summary":"证券之星消息,7月7日,创新药ETF银华基金(159992)跌4.48%,成交额15.94亿元。当日份额增加了6660万份,最新份额为203.06亿份,近20个交易日份额增加10.67亿份。当日资金净流出7.24亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为169.01亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-6.7%,近一个月超额回报为0.41%,管理人为银华基金公司,基金经理为马君 王帅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800007328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649677551","title":"【ETF动向】7月6日创新药ETF银华基金涨0.93%,份额减少1.79亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649677551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649677551?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:04","pubTimestamp":1783382649,"startTime":"0","endTime":"0","summary":"证券之星消息,7月6日,创新药ETF银华基金(159992)涨0.93%,成交额20.95亿元。当日份额减少了1.79亿份,最新份额为202.4亿份,近20个交易日份额增加11.39亿份。当日资金净流入2194.26万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为176.25亿元。创新药ETF银华基金跟踪标的为中证创新药产业指数,成立(2020-03-20)以来超额回报为-7.05%,近一个月超额回报为0.37%,管理人为银华基金公司,基金经理为马君 王帅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700006148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649677302","title":"【ETF动向】7月6日创新药ETF富国基金涨1.8%,份额增加1.22亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2649677302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649677302?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:03","pubTimestamp":1783382590,"startTime":"0","endTime":"0","summary":"证券之星消息,7月6日,创新药ETF富国基金(159748)涨1.8%,成交额3.48亿元。当日份额增加了1.22亿份,最新份额为18.58亿份,近20个交易日份额增加9.08亿份。当日资金净流入1.18亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为14.69亿元。创新药ETF富国基金跟踪标的为中证沪港深创新药产业人民币指数,成立(2021-11-24)以来超额回报为0.08%,近一个月超额回报为0.17%,管理人为富国基金公司,基金经理为蔡卡尔。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700005963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159316"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784350424163,"stockEarnings":[{"period":"1week","weight":-0.0334},{"period":"1month","weight":0.1364},{"period":"3month","weight":-0.1965},{"period":"6month","weight":-0.2069},{"period":"1year","weight":-0.2598},{"period":"ytd","weight":-0.1249}],"compareEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":-0.0837},{"period":"3month","weight":-0.0709},{"period":"6month","weight":-0.0823},{"period":"1year","weight":0.0703},{"period":"ytd","weight":-0.0516}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药E,159316,创新药E股票,创新药E股票老虎,创新药E股票老虎国际,创新药E行情,创新药E股票行情,创新药E股价,创新药E股市,创新药E股票价格,创新药E股票交易,创新药E股票购买,创新药E股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药E(159316)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药E(159316)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}